house resolution no.69
Reps. Vaupel and LaFave offered the following resolution:
Whereas, Tardive Dyskinesia (TD) is a condition of involuntary muscle movements of the face, trunk, and extremities that can vary in frequency and amplitude; and
Whereas, TD is a condition that may occur with certain medications used to treat mental illness. TD results from treatment with dopamine receptor blocking agents used for both psychiatric and non-psychiatric conditions, and can persist even after continuing treatment; and
Whereas, Research done by The Citizens Commission on Human Rights shows that more than 12 million Americans take antipsychotics and that more than 500,000 of those patients may have TD; and
Whereas, Anyone taking an antipsychotic medication may develop TD, but people who are elderly, female, diabetic, or have a mental illness are at a greater risk of developing TD; now, therefore, be it
Resolved by the House of Representatives, That the members of this legislative body declare May 4-11, 2019, as Tardive Dyskinesia Awareness Week in the state of Michigan; and be it further
Resolved, That we acknowledge the significant interest of the state of Michigan to increase public awareness of Tardive Dyskinesia, a neurological disorder that is characterized by repetitive, involuntary muscle movements and may occur as a side effect of long-term use of antipsychotic and other medications.